메뉴 건너뛰기




Volumn 31, Issue 4, 2011, Pages 528-531

Adding aripiprazole to clozapine worsened delusions and hallucinations: A case report

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; CLOZAPINE; NEUROLEPTIC AGENT; THIORIDAZINE;

EID: 79960607294     PISSN: 02710749     EISSN: 1533712X     Source Type: Journal    
DOI: 10.1097/JCP.0b013e3182223b13     Document Type: Letter
Times cited : (5)

References (14)
  • 1
    • 34748841969 scopus 로고    scopus 로고
    • Combination therapy with non-clozapine atypical antipsychotic medication: A review of current evidence
    • DOI 10.1177/0269881106071334
    • Chan J, Sweeting M. Review: combination therapy with non-clozapine atypical antipsychotic medication: a review of current evidence. J Psychopharmacol. 2007;21(6):657-664. (Pubitemid 47472722)
    • (2007) Journal of Psychopharmacology , vol.21 , Issue.6 , pp. 657-664
    • Chan, J.1    Sweeting, M.2
  • 2
    • 0037407492 scopus 로고    scopus 로고
    • Aripiprazole: Does partial dopaminergic agonism translate into clinical benefits?
    • DOI 10.1345/aph.1D014
    • Crismon ML, DeLeon A, Miller AL. Aripiprazole: does partial dopaminergic agonism translate into clinical benefits? Ann Pharmacother. 2003;37:738-740. (Pubitemid 36523072)
    • (2003) Annals of Pharmacotherapy , vol.37 , Issue.5 , pp. 738-740
    • Crismon, M.L.1    DeLeon, A.2    Miller, A.L.3
  • 3
    • 45249113944 scopus 로고    scopus 로고
    • Aripiprazole augmentation in clozapine-treated patients with refractory schizophrenia: An 8-week, randomized, double-blind, placebo-controlled trial
    • Chang JS, Ahn YM, Park HJ, et al. Aripiprazole augmentation in clozapine-treated patients with refractory schizophrenia: an 8 week, randomized, double-blind, placebo-controlled trial. J Clin Psychiatry. 2008;69(5): 720-731. (Pubitemid 351838681)
    • (2008) Journal of Clinical Psychiatry , vol.69 , Issue.5 , pp. 720-731
    • Chang, J.S.1    Ahn, Y.M.2    Park, H.J.3    Lee, K.Y.4    Kim, S.H.5    Kang, U.G.6    Kim, Y.S.7
  • 5
    • 33751119908 scopus 로고    scopus 로고
    • Clozapine augmented with aripiprazole in 5 patients with schizophrenia [4]
    • DOI 10.1097/01.jcp.0000246206.65411.f5, PII 0000471420061200000023
    • Abu-Tair F, Kopitz J, Bergemann N. Clozapine augmented with aripiprazole in 5 patients with schizophrenia. J Clin Psychopharmacol. 2006;26(6):669-671. (Pubitemid 44772751)
    • (2006) Journal of Clinical Psychopharmacology , vol.26 , Issue.6 , pp. 669-671
    • Abu-Tair, F.1    Kopitz, J.2    Bergemann, N.3
  • 7
    • 1442332132 scopus 로고    scopus 로고
    • Worsened agitation with aripiprazole: Adverse effect of dopamine partial agonism?
    • DeQuardo JR. Worsened agitation with aripiprazole: adverse effect of dopamine partial agonism? J Clin Psychiatry. 2004;65(1):132-133.
    • (2004) J Clin Psychiatry. , vol.65 , Issue.1 , pp. 132-133
    • Dequardo, J.R.1
  • 8
    • 3042699593 scopus 로고    scopus 로고
    • Worsening schizoaffective disorder with aripiprazole
    • Reeves RR, Mack JE. Worsening schizoaffective disorder with aripiprazole. Am J Psychiatry. 2004;161(7):1308.
    • (2004) Am J Psychiatry. , vol.161 , Issue.7 , pp. 1308
    • Reeves, R.R.1    MacK, J.E.2
  • 9
    • 34249714698 scopus 로고    scopus 로고
    • Aripiprazole and worsening of psychosis: A case report [9]
    • Ahuja N, Lloyd AJ. Aripiprazole and worsening of psychosis: a case report. J Clin Psychiatry. 2007;68(5): 805-806. (Pubitemid 46841875)
    • (2007) Journal of Clinical Psychiatry , vol.68 , Issue.5 , pp. 805-806
    • Ahuja, N.1    Lloyd, A.J.2
  • 11
    • 61349197541 scopus 로고    scopus 로고
    • Aripiprazole in combination with other antipsychotic drugs may worsen psychosis
    • Adan-Manes J, Garcia-Parajua P. Aripiprazole in combination with other antipsychotic drugs may worsen psychosis. J Clin Pharm Ther. 2009;34(2):245-246.
    • (2009) J Clin Pharm Ther. , vol.34 , Issue.2 , pp. 245-246
    • Adan-Manes, J.1    Garcia-Parajua, P.2
  • 12
    • 72849140996 scopus 로고    scopus 로고
    • A multicenter, randomized, double-blind, placebo-controlled, 16-week study of adjunctive aripiprazole for schizophrenia or schizoaffective disorder inadequately treated with quetiapine or risperidone monotherapy
    • Kane JM, Correll CU, Goff DC, et al. A multicenter, randomized, double-blind, placebo-controlled, 16-week study of adjunctive aripiprazole for schizophrenia or schizoaffective disorder inadequately treated with quetiapine or risperidone monotherapy. J Clin Psychiatry. 2009;70(10):1348-1357.
    • (2009) J Clin Psychiatry. , vol.70 , Issue.10 , pp. 1348-1357
    • Kane, J.M.1    Correll, C.U.2    Goff, D.C.3
  • 13
    • 77957230409 scopus 로고    scopus 로고
    • Effects of adjunctive treatment with aripiprazole on body weight and clinical efficacy in schizophrenia patients treated with clozapine: A randomized, double-blind, placebo-controlled trial
    • Fleischhacker WW, Heikkinen ME, Olié JP, et al. Effects of adjunctive treatment with aripiprazole on body weight and clinical efficacy in schizophrenia patients treated with clozapine: a randomized, double-blind, placebo-controlled trial. Int J Neuropsychopharmacol. 2010;13(8):1115-1125.
    • (2010) Int J Neuropsychopharmacol. , vol.13 , Issue.8 , pp. 1115-1125
    • Fleischhacker, W.W.1    Heikkinen, M.E.2    Olié, J.P.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.